![](https://investorshub.advfn.com/uicon/434772.png?cb=1479377918)
Wednesday, February 21, 2018 4:21:56 PM
Management reminded today they are aligned with shareholders and they HOLD LONG TERM their shares, they didn't sell at 3.23$ and they are CONFIDENT we will recover that value and higher in long term!
No dilution!
Cash on hands for 2018!
Only one direction for share we skyrocket from 0.40 and the direction is 1B market cap!
Did you notice that the Neuroderm sold to for 1B at 39$ PPS was having a couple of products between phase 1 and phase 2?
Which means OWCP after phase 1 and safety trial completed for canapsor should be fairly valued 5-10$ PPS !! Adding that they will sell it before as cosmetic generating revenue... And you see this is just a BUY
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM